Abstract
Mechanical ventilation remains the cornerstone of respiratory support for patients with acute respiratory failure. However, high pressure and volume associated with tidal ventilation are known to aggravate lung injury in this setting [1]. Furthermore, profound gas-exchange abnormalities threatening patients’ lives can occur in the most severe forms of the disease despite recourse to conventional salvage therapies [2, 3]. Extracorporeal gas exchange devices, i. e., venovenous extracorporeal membrane oxygenation (ECMO) and extracorporeal carbon dioxide removal (ECCO2R), were developed more than 40 years ago [4, 5] to rescue these dying patients. Whereas venovenous ECMO provides complete extracorporeal blood oxygenation and decarboxylation using high blood flows (4–6 l/min) and large (20–30 Fr) cannulas [6–9], efficient extracorporeal CO2 removal (with minimal blood oxygenation) can be achieved with ECCO2R devices using limited extracorporeal blood flow (0.4–1 l/min) and thin double lumen venous catheters (14–18 Fr) [10, 11], because CO2 clearance is more effective than oxygenation due to the greater solubility and more rapid diffusion of CO2 [12]. Extracorporeal gas exchange devices also permit ‘ultraprotective’ mechanical ventilation with further reduction of volume and pressure, which may ultimately enhance lung protection and improve clinical outcomes for patients with acute respiratory distress syndrome (ARDS). However, results of trials evaluating extracorporeal gas exchange for respiratory failure performed in the 1970s, 80s and 90s were often disappointing [13, 14]. In recent years, major technological advances have occurred and the latest generation extracorporeal gas exchange devices, with polymethylpentene hollow-fiber membrane lungs and Mendler-designed centrifugal pumps offer lower resistance to blood flow, have smaller priming volumes, higher effective gas exchange properties and are coated with more biocompatible materials.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dreyfuss D, Soler P, Basset G, Saumon G (1988) High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 137:1159–1164
Guerin C, Reignier J, Richard JC et al (2013) Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 368:2159–2168
Papazian L, Forel JM, Gacouin A et al (2010) Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 363:1107–1116
Hill JD, O’Brien TG, Murray JJ et al (1972) Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. N Engl J Med 286:629–634
Kolobow T, Zapol W, Pierce JE, Keeley AF, Replogle RL, Haller A (1968) Partial extracorporeal gas exchange in alert newborn lambs with a membrane artificial lung perfused via an A-V shunt for periods up to 96 hours. Trans Am Soc Artif Intern Organs 14:328–334
Combes A, Brechot N, Luyt CE, Schmidt M (2012) What is the niche for extracorporeal membrane oxygenation in severe acute respiratory distress syndrome? Curr Opin Crit Care 18:527–532
Brodie D, Bacchetta M (2012) Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med 365:1905–1914
Combes A, Bacchetta M, Brodie D, Muller T, Pellegrino V (2012) Extracorporeal membrane oxygenation for respiratory failure in adults. Curr Opin Crit Care 18:99–104
MacLaren G, Combes A, Bartlett RH (2012) Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med 38:210–220
Cove ME, Maclaren G, Federspiel WJ, Kellum JA (2012) Bench to bedside review: Extracorporeal carbon dioxide removal, past present and future. Crit Care 16:232
Bein T, Weber-Carstens S, Goldmann A et al (2013) Lower tidal volume strategy ( approximately 3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study. Intensive Care Med 39:847–856
Schmidt M, Tachon G, Devilliers C et al (2013) Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adults. Intensive Care Med 39:838–846
Zapol WM, Snider MT, Hill JD et al (1979) Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 242:2193–2196
Morris AH, Wallace CJ, Menlove RL et al (1994) Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 149:295–305
Davies A, Jones D, Bailey M et al (2009) Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA 302:1888–1895
Noah MA, Peek GJ, Finney SJ et al (2011) Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA 306:1659–1668
Pham T, Combes A, Roze H et al (2013) Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: A cohort study and propensity-matched analysis. Am J Respir Crit Care Med 187:276–285
Peek GJ, Mugford M, Tiruvoipati R et al (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374:1351–1363
Terragni PP, Del Sorbo L, Mascia L et al (2009) Tidal volume lower than 6 ml/kg enhances lung protection: role of extracorporeal carbon dioxide removal. Anesthesiology 111:826–835
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269 (W264)
Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12
Wells GA, Shea B, O’Connell D et al The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Chalmers TC, Smith H Jr, Blackburn B et al (1981) A method for assessing the quality of a randomized control trial. Control Clin Trials 2:31–49
Mitchell MD, Mikkelsen ME, Umscheid CA, Lee I, Fuchs BD, Halpern SD (2010) A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic. Crit Care Med 38:1398–1404
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605
Brogan TV, Thiagarajan RR, Rycus PT, Bartlett RH, Bratton SL (2009) Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database. Intensive Care Med 35:2105–2114
Hemmila MR, Rowe SA, Boules TN et al (2004) Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg 240:595–605
Mols G, Loop T, Geiger K, Farthmann E, Benzing A (2000) Extracorporeal membrane oxygenation: a ten-year experience. Am J Surg 180:144–154
Lewandowski K, Rossaint R, Pappert D et al (1997) High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Intensive Care Med 23:819–835
Beiderlinden M, Eikermann M, Boes T, Breitfeld C, Peters J (2006) Treatment of severe acute respiratory distress syndrome: role of extracorporeal gas exchange. Intensive Care Med 32:1627–1631
Lindskov C, Jensen RH, Sprogoe P et al (2013) Extracorporeal membrane oxygenation in adult patients with severe acute respiratory failure. Acta Anaesthesiol Scand 57:303–311
Schmid C, Philipp A, Hilker M et al (2012) Venovenous extracorporeal membrane oxygenation for acute lung failure in adults. J Heart Lung Transplant 31:9–15
Schmidt M, Zogheib E, Roze H et al (2013) The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med 39:1704–1713
Forrest P, Ratchford J, Burns B et al (2011) Retrieval of critically ill adults using extracorporeal membrane oxygenation: an Australian experience. Intensive Care Med 37:824–830
Muller T, Philipp A, Luchner A et al (2009) A new miniaturized system for extracorporeal membrane oxygenation in adult respiratory failure. Crit Care 13:R205
Schmidt M, Brechot N, Hariri S et al (2012) Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Clin Infect Dis 55:1633–1641
Chan KK, Lee KL, Lam PK, Law KI, Joynt GM, Yan WW (2010) Hong Kong’s experience on the use of extracorporeal membrane oxygenation for the treatment of influenza A (H1N1). Hong Kong Med J 16:447–454
D’Ancona G, Capitanio G, Chiaramonte G et al (2011) Extracorporeal membrane oxygenator rescue and airborne transportation of patients with influenza A (H1N1) acute respiratory distress syndrome in a Mediterranean underserved area. Interact Cardiovasc Thorac Surg 12:935–937
Freed DH, Henzler D, White CW et al (2010) Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada. Can J Anaesth 57:240–247
Holzgraefe B, Broome M, Kalzen H, Konrad D, Palmer K, Frenckner B (2010) Extracorporeal membrane oxygenation for pandemic H1N1 2009 respiratory failure. Minerva Anestesiol 76:1043–1051
Roch A, Lepaul-Ercole R, Grisoli D et al (2010) Extracorporeal membrane oxygenation for severe influenza A (H1N1) acute respiratory distress syndrome: a prospective observational comparative study. Intensive Care Med 36:1899–1905
Roncon-Albuquerque R Jr., Basilio C, Figueiredo P et al (2012) Portable miniaturized extracorporeal membrane oxygenation systems for H1N1-related severe acute respiratory distress syndrome: A case series. J Crit Care 27:454–463
Takeda S, Kotani T, Nakagawa S et al (2012) Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) severe respiratory failure in Japan. J Anesth 26:650–657
Turner DA, Rehder KJ, Peterson-Carmichael SL et al (2011) Extracorporeal membrane oxygenation for severe refractory respiratory failure secondary to 2009 H1N1 influenza A. Respir Care 56:941–946
Hou X, Guo L, Zhan Q et al (2012) Extracorporeal membrane oxygenation for critically ill patients with 2009 influenza A (H1N1)-related acute respiratory distress syndrome: preliminary experience from a single center. Artif Organs 36:780–786
Michaels AJ, Hill JG, Bliss D et al (2013) Pandemic flu and the sudden demand for ECMO resources: a mature trauma program can provide surge capacity in acute critical care crises. J Trauma Acute Care Surg 74:1493–1497
Bonastre J, Suberviola B, Pozo JC et al (2012) Extracorporeal lung support in patients with severe respiratory failure secondary to the 2010–2011 winter seasonal outbreak of influenza A (H1N1) in Spain. Med Intensiva 36:193–199
Patroniti N, Zangrillo A, Pappalardo F et al (2011) The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks. Intensive Care Med 37:1447–1457
Roch A, Hraiech S, Masson E et al (2014) Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center. Intensive Care Med 40:74–83
Schmidt M, Bailey M, Sheldrake J et al (2014) Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) Score. Am J Respir Crit Care Med 189:1374–1382
Enger T, Philipp A, Videm V et al (2014) Prediction of mortality in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation: a prospective observational study. Crit Care 18:R67
Pappalardo F, Pieri M, Greco T et al (2013) Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score. Intensive Care Med 39:275–281
Campbell BT, Braun TM, Schumacher RE, Bartlett RH, Hirschl RB (2003) Impact of ECMO on neonatal mortality in Michigan (1980–1999). J Pediatr Surg 38:290–295
Jen HC, Shew SB (2010) Hospital readmissions and survival after nonneonatal pediatric ECMO. Pediatrics 125:1217–1223
Karamlou T, Vafaeezadeh M, Parrish AM et al (2013) Increased extracorporeal membrane oxygenation center case volume is associated with improved extracorporeal membrane oxygenation survival among pediatric patients. J Thorac Cardiovasc Surg 145:470–475
Extracorporeal membrane oxygenation for severe acute respiratory failure in adults: NHS NICE GUIDANCE Available at: http://www.nice.org.uk/guidance/IPG391 Accessed December 2014
ECMOnet. Available at: http://www.ecmonet.org/. Accessed March 14th 2014
NSW Critical Care Tertiary Referral Networks and Transfer of Care (ADULTS). Available at: http://www0.health.nsw.gov.au/policies/pd/2010/pdf/PD2010_021.pdf Accessed December 14, 2014
Combes A, Brodie D, Bartlett R et al (2014) Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients. Am J Respir Crit Care Med 190:488–496
Beurtheret S, Mordant P, Paoletti X et al (2013) Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J 34:112–120
Linden V, Palmer K, Reinhard J et al (2000) High survival in adult patients with acute respiratory distress syndrome treated by extracorporeal membrane oxygenation, minimal sedation, and pressure supported ventilation. Intensive Care Med 26:1630–1637
Linden VB, Lidegran MK, Frisen G, Dahlgren P, Frenckner BP, Larsen F (2009) ECMO in ARDS: a long-term follow-up study regarding pulmonary morphology and function and health-related quality of life. Acta Anaesthesiol Scand 53:489–495
Herridge MS, Cheung AM, Tansey CM et al (2003) One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348:683–693
Schelling G, Stoll C, Haller M et al (1998) Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome. Crit Care Med 26:651–659
Luyt CE, Combes A, Becquemin MH et al (2012) Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. Chest 142:583–592
Hodgson CL, Hayes K, Everard T et al (2012) Long-term quality of life in patients with acute respiratory distress syndrome requiring extracorporeal membrane oxygenation for refractory hypoxaemia. Crit Care 16:R202
Gattinoni L, Pesenti A, Mascheroni D et al (1986) Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA 256:881–886
Iglesias M, Martinez E, Badia JR, Macchiarini P (2008) Extrapulmonary ventilation for unresponsive severe acute respiratory distress syndrome after pulmonary resection. Ann Thorac Surg 85:237–244
Florchinger B, Philipp A, Klose A et al (2008) Pumpless extracorporeal lung assist: a 10-year institutional experience. Ann Thorac Surg 86:410–417 (discussion 417)
The Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308
EOLIA trial. Available at: http://www.clinicaltrials.gov/ct2/show/NCT01470703?term=eo-lia&rank=1. Accessed December 2014
SUPERNOVA trial of ECCO2-R for moderate ARDS. Available at: http://www.esicm.org/research/trials-group/supernova. Accessed December 2014
Paden ML, Conrad SA, Rycus PT, Thiagarajan RR (2013) Extracorporeal Life Support Organization Registry Report 2012. ASAIO J 59:202–210
Rega FR, Evrard V, Bollen H et al (2007) pH 48 h after onset of extracorporeal membrane oxygenation is an independent predictor of survival in patients with respiratory failure. Artif Organs 31:384–389
Frenckner B, Palmer P, Linden V (2002) Extracorporeal respiratory support and minimally invasive ventilation in severe ARDS. Minerva Anestesiol 68:381–386
Macha M, Griffith BP, Keenan R et al (1996) ECMO support for adult patients with acute respiratory failure. ASAIO J 42:M841–844
Cordell-Smith JA, Roberts N, Peek GJ, Firmin RK (2006) Traumatic lung injury treated by extracorporeal membrane oxygenation (ECMO). Injury 37:29–32
Haneya A, Philipp A, Foltan M et al (2012) First experience with the new portable extracorporeal membrane oxygenation system Cardiohelp for severe respiratory failure in adults. Perfusion 27:150–155
Huang YK, Liu KS, Lu MS, Wu MY, Tsai FC, Lin PJ (2009) Extracorporeal life support in post-traumatic respiratory distress patients. Resuscitation 80:535–539
Isgro S, Patroniti N, Bombino M et al (2011) Extracorporeal membrane oxygenation for interhospital transfer of severe acute respiratory distress syndrome patients: 5-year experience. Int J Artif Organs 34:1052–1060
Oshima K, Kunimoto F, Hinohara H et al (2010) Evaluation of prognosis in patients with respiratory failure requiring venovenous extracorporeal membrane oxygenation (ECMO). Ann Thorac Cardiovasc Surg 16:156–162
Bermudez CA, Rocha RV, Sappington PL, Toyoda Y, Murray HN, Boujoukos AJ (2010) Initial experience with single cannulation for venovenous extracorporeal oxygenation in adults. Ann Thorac Surg 90:991–995
Goulon M, Raphael JC, Gajdos P, Barois A, Babinet P, Margent P (1978) Membrane oxygenators for acute respiratory insufficiency. Clinical use in 11 patients. Intensive Care Med 4:173–179
Park M, Azevedo LC, Mendes PV et al (2012) First-year experience of a Brazilian tertiary medical center in supporting severely ill patients using extracorporeal membrane oxygenation. Clinics (Sao Paulo, Brazil) 67:1157–1163
Park YH, Hwang S, Park HW et al (2012) Effect of pulmonary support using extracorporeal membrane oxygenation for adult liver transplant recipients with respiratory failure. Transplant Proc 44:757–761
Rossaint R, Pappert D, Gerlach H, Lewandowski K, Keh D, Falke K (1997) Extracorporeal membrane oxygenation for transport of hypoxaemic patients with severe ARDS. Br J Anaesth 78:241–246
Brunet F, Belghith M, Mira JP et al (1993) Extracorporeal carbon dioxide removal and low-frequency positive-pressure ventilation. Improvement in arterial oxygenation with reduction of risk of pulmonary barotrauma in patients with adult respiratory distress syndrome. Chest 104:889–898
Muellenbach RM, Kredel M, Wunder C et al (2008) Arteriovenous extracorporeal lung assist as integral part of a multimodal treatment concept: a retrospective analysis of 22 patients with ARDS refractory to standard care. Eur J Anaesthesiol 25:897–904
Nierhaus A, Frings D, Braune S et al (2011) Interventional lung assist enables lung protective mechanical ventilation in acute respiratory distress syndrome. Minerva Anestesiol 77:797–801
Cho WH, Lee K, Huh JW, Lim CM, Koh Y, Hong SB (2012) Physiologic effect and safety of the pumpless extracorporeal interventional lung assist system in patients with acute respiratory failure – a pilot study. Artif Organs 36:434–438
Conrad SA, Zwischenberger JB, Grier LR, Alpard SK, Bidani A (2001) Total extracorporeal arteriovenous carbon dioxide removal in acute respiratory failure: a phase I clinical study. Intensive Care Med 27:1340–1351
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland and BioMed Central Ltd.
About this chapter
Cite this chapter
Schmidt, M., Hodgson, C., Combes, A. (2015). Extracorporeal Gas Exchange for Acute Respiratory Failure in Adult Patients: A Systematic Review. In: Vincent, JL. (eds) Annual Update in Intensive Care and Emergency Medicine 2015. Annual Update in Intensive Care and Emergency Medicine 2015, vol 2015. Springer, Cham. https://doi.org/10.1007/978-3-319-13761-2_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-13761-2_14
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-13760-5
Online ISBN: 978-3-319-13761-2
eBook Packages: MedicineMedicine (R0)